legal status OTC small Canada Ca small routes of administration Oral Naproxen sodium International Nonproprietary ... . Naproxen and naproxen sodium are marketed under various trade names, including Aleve , Anaprox , Antalgin ... , Naprosyn , Narocin , Proxen , Synflex and Xenobid . Naproxen was originally marketed as the prescription drug Naprosyn by Syntex in 1976, and naproxen sodium was first marketed under the trade ... mg tablets of naproxen sodium are Standard for the Uniform Scheduling of Drugs and Poisons Schedule ... mg. In the United Kingdom, 250 mg tablets of naproxen were approved for OTC sale under the brand ... of OTC naproxen Feminax Ultra url http www.druginfozone.nhs.uk Record 20Viewing viewRecord.aspx ... Uses Naproxen is commonly used for the reduction of pain , fever , inflammation , and stiffness caused ... 24 March 2012 ref Naproxen works by inhibiting both the COX 1 and COX 2 enzymes . Risks and adverse ... evaluated, naproxen was associated with the smallest overall cardiovascular risks. ref name Trelle ... NSAIDs, naproxen can cause gastrointestinal problems such as heartburn, constipation, diarrhea, ulcers, and stomach bleeding ref http www.ncbi.nlm.nih.gov pubmedhealth PMH0000526 Naproxen PubMed ... taking naproxen. Consumption of alcohol may increase the risk of gastrointestinal complications. NSAID painkillers, such as naproxen, may interfere and reduce the efficiency of SSRI antidepressants ... by antiinflammatory drugs in mice and humans PNAS 2011 ref Compound information Naproxen is a member ... point of 152 155& 160 Celsius C . Synthesis Naproxen has been industrially produced by Syntex as follows ... 72 76 title Twenty Years of Naproxen Technology author Peter J. Harrington and Eric Lodewijk doi ... External links Wiktionary naproxen PubChemLink 1302 EINECSLink 244 838 7 http www.nlm.nih.gov medlineplus druginfo meds a681029.html MedlinePlus Information on naproxen http www.fda.gov NewsEvents Newsroom PressAnnouncements 2004 ucm108387.htm FDA Statement on Naproxen , released 20 December 2004 http ... more details
Infobox basketball club color1 white color2 red name Pharex Naproxen Sodium Bidang Generix logo Pharex genrix.png 220px leagues Philippine Basketball League 2007 2010 br PBA Developmental League 2011 present founded 2007 history Pharex Medics br 2007 2008 br Pharex Generix br 2008 br Pharex Bidang Generix br 2009 br Ascof Lagundi Natural Cough Busters br 2010 br Pharex Naproxen Sodium Bidang Generix br 2011 present arena location Philippines nickname colors Blue, White president coach Gian Carlo Tan championships website http pbl.org.ph pharex lineup.php PBL website h pattern b bluestriped sides h body ffffff h shorts ffffff h pattern s blanksides2 a pattern b a body 000080 a shorts 000080 The Pharex Naproxen Sodium Bidang Generix is a basketball team currently playing in the PBA Developmental League and is owned by Pascual Laboratories, Inc. . The team also played for the Philippine Basketball League from 2007 to 2010. Current roster PBADL Pharex Naproxen Sodium Bidang Generix roster External links http www.pascuallab.com product.php?id 550 Pascual Laboratories, Inc. Ascof Lagundi Syrup website http www.pascuallab.com Pascual Laboratories, Inc. website http www.pbl.org.ph ascof lineup.php Ascof Lagundi PBL website DEFAULTSORT Pharex Naproxen Sodium Bidang Generix Category Former Philippine Basketball League teams Category PBA Developmental League teams Philippines basketball team stub ... more details
DISPLAYTITLE C sub 14 sub H sub 14 sub O sub 3 sub The molecular formula C sub 14 sub H sub 14 sub O sub 3 sub molar mass 230.25 g mol may refer to Kavain Naproxen Pindone Molecular formula disambiguation sr C14H14O3 ... more details
who are highly prone to sunburn are more likely to develop naproxen induced pseudoporphyria than ... of developing shallow scars on the face while taking naproxen . History A careful history is of utmost ... mimics EPP has been described almost exclusively in children taking naproxen for juvenile rheumatoid arthritis. Naproxen induced pseudoporphyria seems to have a dimorphic presentation with the PCT ... is naproxen . A frequent source of UV A exposure is tanning booth s. As recognition of pseudoporphyria ... ref Suarez SM, Cohen PR, DeLeo VA. Bullous photosensitivity to naproxen pseudoporphyria . Arthritis Rheum. Jun 1990 33 6 903 8 ref Propionic acid derivatives NSAIDs naproxen, diflunisal , ketoprofen ... more details
Antibe Therapeutics is a Toronto based pharmaceutical research and development company developing inflammation reducing drugs. ref http www.antibe therapeutics.com ref The conceived mechanism of action is to deliver a gaseous mediator , specifically hydrogen sulfide to sites of inflammation or injury within the human body. Hydrogen sulfide enhances the resolution of injury and repair of damage. Antibe was founded by John L. Wallace , co founder of NicOx , the company that was the first to commercialize gaseous mediator technology. Antibe s board of directors includes Louis Ignarro , awarded the 1998 Nobel Prize in Physiology or Medicine for the basic research that underpins gaseous mediator technology, and Dr. Daniel K. Podolsky, Presient of the University of Texas Southwestern . Antibe s products have not yet been approved by the Food and Drug Administration . The lead drug, ATB 346, is a hydrogen sulfide releasing derivative of naproxen, a commonly used non steroidal anti inflammatory drug . Unlike naproxen, ATB 346 does not induce damage in the gastrointestinal tract. Canada company stub References reflist External links http www.nicox.com Official website of NicOx http www.nitricoxideonline.net Nitric Oxide Knowledge Center Website of NicOx Category Pharmaceutical companies of France Category SBF 120 de Nicox fr Nicox http www.ncbi.nlm.nih.gov pmc articles PMC1363746 ... more details
Infobox disease Name Photosensitive drug reaction Image Alt Caption DiseasesDB ICD10 ICD9 ICDO OMIM MedlinePlus eMedicineSubj article eMedicineTopic 1049648 MeshID GeneReviewsID GeneReviewsName Photosensitive drug reaction or drug induced photosensitivity secondary to medications may cause phototoxic, photoallergic, and lichenoid reactions, and photodistributed telangiectasias , as well as pseudoporphyria. ref name Andrews James, William Berger, Timothy Elston, Dirk 2005 . Andrews Diseases of the Skin Clinical Dermatology . 10th ed. . Saunders. ISBN 0 7216 2921 0. ref rp 121 Drugs involved include naproxen and doxycycline . See also Skin lesion List of cutaneous conditions References reflist Cutaneous condition stub Category Drug eruptions ... more details
showed that naproxcinod had similar efficacy to naproxen measured in WOMAC Pain, function ... Inhibiting Nitric Oxide Donator Naproxcinod Versus Naproxen on Systemic Blood Pressure ... anti inflammatory drug s increase blood pressure , and naproxen is one of the safest in this regard ... neutral , while the comparator naproxen sold under the brand Aleve in the United States showed a statistically ... more details
COX inhibiting nitric oxide donators CINODs , also known as NO NSAIDs , are a new class of non steroidal anti inflammatory drug NSAID developed with the intention of providing greater safety than existing NSAIDs. These compounds were first described by John Wallace ref http www.ucalgary.ca irn wallace.htm John Wallace, Professor, Department of Pharmacology and Therapeutics, University of Calgary ref and colleagues. CINODs are Chemical compound compound s generated by the fusion of an existing NSAID with a nitric oxide NO donating functional group moiety by chemical means, usually by Ester Ester reactions ester linkage . CINODs retain the anti inflammatory efficacy of NSAIDs via inhibition of cyclooxygenase COX while arguably improving upon gastric and vascular safety, most likely via vasorelaxation , inhibition of leukocyte cell adhesion adhesion and inhibition of caspases , all known effects of NO. The first CINODs were developed in the 1990s, and as yet none have been approved for use by the general public. The importance of developing such drugs was increased when COX 2 inhibitor COX 2 specific NSAIDs rofecoxib Vioxx and lumiracoxib Prexige were removed from major pharmaceutical markets in the mid 2000s due to COX 2 inhibitor Risks and adverse effects vascular safety concerns . In addition, traditional NSAIDs increase blood pressure and interfere with the actions of antihypertensive drugs. Several CINODs are currently being tested in clinical trials , the most advanced of which are being conducted by the France French pharmaceutical company NicOx , whose flagship compound naproxcinod NO naproxen, nitronaproxen is in clinical trials Phase III phase III trials for the treatment of osteoarthritis . ref http www.drugdevelopment technology.com projects azd3582 HCT 3012 COX Inhibiting Nitric Oxide Donator CINOD for Relief of Pain and Inflammation ref Naproxcinod is a fusion of naproxen and a NO donating group. Other CINODs are also being tested by NicOx for the treatme ... more details
ATC codes lead M 02 Topical products for joint and muscular pain vet add anchor M02A M02A Topical products for joint and muscular pain anchor M02AA M02AA Anti inflammatory preparations, non steroids for topical use M02AA01 Phenylbutazone M02AA02 Mofebutazone M02AA03 Clofezone M02AA04 Oxyphenbutazone M02AA05 Benzydamine M02AA06 Etofenamate M02AA07 Piroxicam M02AA08 Felbinac M02AA09 Bufexamac M02AA10 Ketoprofen M02AA11 Bendazac M02AA12 Naproxen M02AA13 Ibuprofen M02AA14 Fentiazac M02AA15 Diclofenac M02AA16 Feprazone M02AA17 Niflumic acid M02AA18 Meclofenamic acid M02AA19 Flurbiprofen M02AA21 Tolmetin M02AA22 Suxibuzone M02AA23 Indometacin M02AA24 Nifenazone M02AA25 Aceclofenac M02AA26 Nimesulide QM02AA99 Antiinflammatory preparations, non steroids for topical use, combinations anchor M02AB M02AB Capsaicin and similar agents M02AB01 Capsaicin M02AB02 Zucapsaicin anchor M02AC M02AC Preparations with salicylic acid derivatives QM02AC99 Preparations with salicylic acid derivatives, combinations anchor QM02AQ QM02AQ Blistering agent s anchor M02AX M02AX Other topical products for joint and muscular pain M02AX02 Tolazoline M02AX03 Dimethyl sulfoxide M02AX05 Idrocilamide M02AX10 Various QM02AX53 Dimethyl sulfoxide, combinations References Reflist Topical products for joint and muscular pain NSAIDs Category ATC codes M02 ca Codi ATC M02 cs ATC k d M02 es Anexo C digo ATC M02 ko ATC M02 hu ATC M02 Az z leti s izomf jdalmak kezel s nek helyi k sz tm nyei pl ATC M02 ro Cod ATC M02 sr ATC kod M02 sv ATC kod M02 Utv rtes medel vid led och muskelsm rtor th ATC M02 ... more details
Midol is a brand of an over the counter drug for menstrual cramping and other effects related to premenstrual syndrome and menstruation . Midol is distributed by Bayer . Midol was originally sold in 1911 as a headache and toothache remedy that was considered safer because it did not use the narcotics typically used at the time. ref http www.mum.org midoslog.jpg Midol ad for Headache Neuralgia, Toothache ref It was then promoted as a cure for hiccups claiming it controlled spasms, and finally as a remedy for menstrual cramps and bloating. ref http www.mum.org midol11x.jpg Midol for Hiccoughs ref ref http www.mum.org news.htm News at Museum of Menstruation and women s health ref ref http contexts.org socimages files 2008 07 gender bettys gay with midol.jpg Midol ad for Menstrual problems ref ref http contexts.org socimages files 2008 07 gender reverse the curse.jpg Midol Reverse the Curse ad ref A formulation sold in the 1980s was made with the sympathomimetic , cinnamedrine . ref KW Fellows, AJ Giannini. Cinnamedrine Potential for Abuse. Journal of Toxicology Clinical Toxicology. 20 93 99.1983. ref It had been reported to have abuse potential as an Anorectic appetite suppressant and sympathomimetic agent. The Midol Complete formulation consists of Acetaminophen 500 mg Analgesic Pain Reliever Caffeine 60 mg Stimulant Pyrilamine Maleate 15 mg Antihistamine The Extended Relief formulation consists of Naproxen Sodium 220 mg NSAID , Pain Reliever Fever Reducer The Teen formulation consists of Acetaminophen 500 mg Pain Reliever Pamabrom 25 mg Diuretic The Liquid Gels formulation consists of Ibuprofen 200 mg Pain Reliever The PM formulation consists of Acetaminophen 500 mg Pain Reliever Diphenhydramine Diphenhydramine citrate 38 mg Sedative antihistamine References Reflist External links http www.midol.com Official site Category Bayer brands Category 1911 introductions musculoskeletal drug stub ... more details
The efficacy and safety of flunoxaprofen has been compared with those of Naproxen in rheumatoid ... study using naproxen language Italian journal La Clinica Terapeutica volume 131 issue 2 pages 83 ... title S flunoxaprofen and S naproxen isocyanate two new fluorescent chiral derivatizing agents for an enantiospecific ... more details
Theramine is a Food and Drug Administration FDA regulated medical food designed to address the increased nutritional requirements associated with chronic pain syndrome s ref http www.ptlcentral.com Clinical Data.php Theramine Clinical Study. http www.ptlcentral.com index.php Physician Therapeutics . 2010. Accessed September 2011. ref and low back pain . ref http journals.lww.com americantherapeutics Abstract publishahead A Double Blind Controlled Trial of a Single Dose.99686.aspx A Double Blind Controlled Trial of a Single Dose Naproxen and an Amino Acid Medical Food Theramine for the Treatment of Low Back Pain. http journals.lww.com pages default.aspx Lippincott Williams & Wilkins . 2011. Accessed September 2011. ref Theramine promotes the production of the neurotransmitters that help manage and improve the sensory response to pain and inflammation . Theramine is available by prescription only. Theramine is manufactured according to FDA current Good manufacturing practice Good Manufacturing Practices cGMP . All of the ingredients in Theramine are classified as generally recognized as safe GRAS by the FDA. Theramine is a specialized formula that consists of Choline bitartrate Choline Bitartrate , L arginine , L histidine HCL, L glutamine , L serine , GABA , Griffonia Seed 95 5HTP , Whey protein Whey Protein Hydrolysate , Grape seed extract Grape Seed Extract 85 Polyphenol s , Cinnamon , and Cocoa Extract 6 Theobromine References See Wikipedia Footnotes on how to create references using ref ref tags which will then appear here automatically Reflist External links http multivu.prnewswire.com mnr axona 40271 docs 40271 Isaacson Hi res.pdf Medical Foods Overview of an Emerging Science http dailymed.nlm.nih.gov dailymed drugInfo.cfm?id 49824 Theramine , from http dailymed.nlm.nih.gov U.S. Government DailyMed http www.ptlcentral.com Physician Therapeutics Website http www.fda.gov Food FoodIngredientsPackaging GenerallyRecognizedasSafeGRAS default.htm FDA GRAS Ingredients ... more details
mg dose is equipotent to 500 mg of naproxen for the treatment of inflammation but with the added ... of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic ... is metabolized to naproxen and a nitric oxide donating moiety chemistry moiety . NO has various cardiovascular ... naproxen, especially for the gastroduodenal mucosa, ref cite journal last1 Wilder Smith first1 CH last2 ... Dose effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal ... more details
Gym , San Juan, Metro Manila team1 Cobra Energy Drink Iron Men score1 66 team2 Pharex Naproxen Sodium ..., Metro Manila team1 PC Gilmore Wizards score1 92 team2 Pharex Naproxen Sodium Bidang Generix score2 ... more details
in a rotation step. The Heck reaction is applied industrially in the production of naproxen and the sunscreen component octyl methoxycinnamate . The naproxen synthesis includes a coupling between ... naproxen.svg center 400px The Heck reaction in Naproxen production align center The Heck reaction in Naproxen production Variations Ionic liquid Heck reaction In the presence of an ionic liquid a Heck ... more details
Infobox MLB player name Dale Mohorcic position Pitcher bats Right throws Right birth date birth date and age 1956 1 25 birth place Cleveland, Ohio debutdate May 31 debutyear by 1986 debutteam Texas Rangers baseball Texas Rangers finaldate October 1 finalyear by 1990 finalteam Montreal Expos stat1label Win loss record pitching Win Loss record stat1value 16 21 stat2label Earned run average stat2value 3.49 stat3label Strikeout s stat3value 174 teams nowiki nowiki Texas Rangers baseball Texas Rangers by 1986 by 1988 New York Yankees by 1988 by 1989 Montreal Expos by 1990 Dale Mohorcic born January 25, 1956 in Cleveland, Ohio was a relief pitcher in Major League Baseball from 1986 to 1990. Mohorcic was a star at Cleveland State University . After playing on farm teams for the Toronto Blue Jays and Pittsburgh Pirates , Mohorcic signed with the Texas Rangers baseball Texas Rangers in by 1985 . His first two years, Mohorcic pitched well, having an ERA under 3.00. He holds a major league baseball record of 13 consecutive team games with a relief appearance, which he set from August 6 20, 1986. He was traded on August 30, 1988 to the New York Yankees for Cecilio Guante . His last year was with the Montreal Expos in by 1990 . He shares the Major League record for most consecutive games pitched at 13 with Mike Marshall. In a 1987 game against the Milwaukee Brewers , Mohorcic was accused of doctoring the baseball. Umpires found no evidence of wrongdoing at the time, but after the game Mohorcic complained of a sore throat, and was admitted to a hospital where it was discovered that he was suffering internal bleeding as a result of having Crohn s disease and taking the pain reliever naproxen. It was erroneously reported by Peter Gammons that Mohorcic s bleeding was caused by swallowing sandpaper. Mohorcic played the part of Angels starting pitcher Dave Spiewak in the 1988 movie The Naked Gun . External links Baseballstats br m mohorda01 fangraphs 1009034 cube Dale Mohorcic http ww ... more details
Drugbox IUPAC name 3R 5 3 chloro 4 fluorophenyl 3 methyl 3 pyrimidin 5 ylmethyl 1 1H 1,2,4 triazol 3 yl 1,3 dihydro 2H indol 2 one image TROX 1 structure.png width 220 Clinical data tradename pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X pregnancy category legal AU Unscheduled S2 S3 S4 S5 S6 S7 S8 S9 legal CA legal UK legal US legal status routes of administration Pharmacokinetic data bioavailability protein bound metabolism elimination half life excretion Identifiers CAS number ATC prefix ATC suffix PubChem 25256198 IUPHAR ligand DrugBank ChemSpiderID 24750794 synonyms Chemical data C 22 H 16 Cl 1 F 1 N 6 O 1 molecular weight 434.853 g mol smiles c5ncncc5CC C C2 O c1cc c cc3Cl ccc3F ccc1N2c4nncn4 TROX 1 is a drug which acts as a potent calcium channel blocker blocker of the Ca sub v sub 2 type Voltage dependent calcium channel calcium channels . It was developed as a potential analgesic after the discovery that the selective N type calcium channel Ca sub v sub 2.2 blocker ziconotide is an active analgesic with similar efficacy to strong opioid drugs but comparatively milder side effects. Unlike ziconotide, TROX 1 is not so selective, and also blocks the Cav2.1 Ca sub v sub 2.1 and R type calcium channel Ca sub v sub 2.3 calcium channel subtypes, but it has the great advantage of being orally active, whereas ziconotide must be administered intrathecally , by injection into the spinal fluid. In animal studies of TROX 1, analgesic effects were observed with similar efficacy to NSAID s such as naproxen or diclofenac , and anti allodynia effects equivalent to pregabalin or duloxetine . ref name pmid20439438 cite journal author Abbadie C, McManus OB, Sun SY, Bugianesi RM, Dai G, Haedo RJ, Herrington JB, Kaczorowski GJ, Smith MM, Swensen AM, Warren VA, Williams B, Arneric SP, Eduljee C, Snutch TP, Tringham EW, Jochnowitz N, Liang A, Euan MacIntyre D, McGowan E, Mistry S, White VV, Hoyt SB, London C, Lyons KA, Bunting PB, Volksdorf S, Duffy JL title Analgesic effect ... more details
, diclofenac, or naproxen. Adverse effects On September 27, 2004 Vioxx Rofecoxib was withdrawn ... of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis ... . In the VIGOR trial testing Vioxx 50 mg day versus naproxen for rheumatoid arthritis, Vioxx ... gastrointestinal complications similar to placebo and significantly lower than naproxen 500 mg ... common NSAID regimens in the countries studied diclofenac 100 mg daily and naproxen 1000 ... between Vioxx and Naproxen to Ascertain Gastrointestinal Tolerability and Effectiveness ADVANTAGE ... with 11.2 of people taking naproxen, a reduction of 19 . In addition, after 3 months, 5.9 of people stopped taking Vioxx compared with 8.1 who stopped taking naproxen, a reduction of 27 . ADVANTAGE was the first study comparing the gastrointestinal tolerability of Vioxx and naproxen in a group ... more details
Encyclopedia
top
